eMedicine Specialties > Nephrology > Glomerular Diseases

Glomerulonephritis, Acute: Differential Diagnoses & Workup

Author: Malvinder S Parmar, MB, MS, FRCP(C), FACP, Assistant Professor (VPT), Faculty of Medicine, University of Ottawa; Associate Professor, Department of Internal Medicine, Northern Ontario School of Medicine, Timmins and District Hospital, Canada
Contributor Information and Disclosures

Updated: Jul 2, 2008

Differential Diagnoses

Glomerulonephritis, Crescentic
Goodpasture Syndrome
Glomerulonephritis, Diffuse Proliferative
Hemolytic-Uremic Syndrome
Glomerulonephritis, Membranoproliferative
Nephritis, Interstitial
Glomerulonephritis, Poststreptococcal
Nephritis, Lupus
Glomerulonephritis, Rapidly Progressive

Other Problems to Be Considered

  • Postinfectious GN must be differentiated from the following conditions:
    • IgA nephritis: The latent period between infection and onset of nephritis is 1- 2 days, or it may be concomitant with upper respiratory tract infection (ie, "synpharyngitic" in contrast to 1-3 wk "postpharyngitic nephritis" in PSGN).
    • MPGN (type I, type II): This is a chronic disease, but it can manifest with an acute nephritic picture with hypocomplementemia; failure of acute nephritis to resolve should prompt consideration of this possibility.
    • Lupus nephritis: Gross hematuria is unusual in lupus nephritis.
    • GN of chronic infection: This can manifest as acute nephritis. Unlike PSGN, in which the infection may have resolved by the time nephritis occurs, patients with nephritis of chronic infection have an active infection at the time nephritis becomes evident. Circulating immune complexes play an important role in the pathogenesis of acute GN in these diseases.
    • Vasculitis: Nephritis of MRSA may have vasculitic lesions of the lower extremities.
    • Predominantly nonglomerular diseases: Thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, atheroembolic renal disease, and acute hypersensitivity interstitial nephritis may present with features of acute nephritic syndrome and should be differentiated.

Workup

Laboratory Studies

  • Urinalysis and sediment examination
    • These tests are crucial in the evaluation of patients with acute nephritic syndrome.
    • Look for protein, blood, RBCs and WBCs, dysmorphic red cells, acanthocytes, cellular (ie, RBC, WBC) casts, granular casts, and oval fat bodies. In some instances, marked sterile pyuria is present.
    • Finding RBC casts is an almost pathognomonic sign of GN.
    • Urine electrolytes, urine sodium, and fractional excretion of sodium (FENa) assays are needed to assess salt avidity.
  • Blood, urea, and nitrogen (BUN); serum creatinine; and serum electrolytes (especially serum potassium level)
  • Complete blood cell count
  • Erythrocyte sedimentation rate
  • Complement levels (C3, C4, CH50)
    • Low C3 levels are found in almost all patients with acute poststreptococcal nephritis; C4 levels may be slightly low. Hypocomplementemia is noted in 73.9% of adult patients.
    • Type III cryoglobulinemia may be present.
  • Twenty-four–hour urine test for total protein and creatinine clearance: Remember that creatinine clearance is a "steady-state" measurement. The creatinine clearance may not reveal the true picture because of rapidly changing renal function; therefore, it is better to wait until renal function has stabilized before performing creatinine clearance.
  • Antistreptolysin-O titer (ASOT) or streptozyme titer: Increasing titer levels confirm recent infection. In patients with skin infection, anti-DNase B titers are more sensitive than ASOT for infection with Streptococcus.
  • Antibody to NAPR: Levels are elevated in streptococcal infections with GN but not in streptococcal infections without GN.
  • If MRSA is the inciting agent, then hypocomplementemia is usually not present, but plasma immunoglobulins, especially IgA, are markedly elevated.
  • Qualitative estimation of proteinuria: Determination of high-molecular weight (HMW) protein, like fractional excretion of IgG (FEIgG), and low-molecular weight (LMW) protein, like alpha-1-microglobulin, may help predict the clinical outcome and may help in guiding steroid and immunosuppressive therapy, especially in patients with primary glomerular diseases with nephrotic syndrome.

Imaging Studies

  • Abdominal ultrasound
    • Assesses renal size
    • Assesses echogenicity of renal cortex
    • Excludes obstruction

Procedures

  • Generally, a renal biopsy is not necessary for a diagnosis of acute PSGN; however, in most cases, it is important because histology guides both prognosis and therapy.

Histologic Findings

Diffuse endocapillary proliferative changes are found (see Media files 1-2). The most common histologic patterns are diffuse (72.1%), focal (12.8%), and mesangial (8.1%) proliferative GN in adults.1 In postinfectious GN, the glomerulus is hypercellular with marked cellular infiltration (ie, polymorphonuclear neutrophils, monocytes). Immunofluorescence may show fine granular deposits of immunoglobulin G in a "starry sky" appearance (see Media file 3). Large subepithelial deposits may be observed on electron microscopy (see Media file 4). Crescents may be observed.

More on Glomerulonephritis, Acute

Overview: Glomerulonephritis, Acute
Differential Diagnoses & Workup: Glomerulonephritis, Acute
Treatment & Medication: Glomerulonephritis, Acute
Follow-up: Glomerulonephritis, Acute
Multimedia: Glomerulonephritis, Acute
References

References

  1. Nasr SH, Markowitz GS, Stokes MB, et al. Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore). Jan 2008;87(1):21-32. [Medline].

  2. Arze RS, Rashid H, Morley R, et al. Shunt nephritis: report of two cases and review of the literature. Clin Nephrol. Jan 1983;19(1):48-53. [Medline].

  3. Baldwin DS, Gluck MC, Schacht RG, et al. The long-term course of poststreptococcal glomerulonephritis. Ann Intern Med. Mar 1974;80(3):342-58. [Medline].

  4. Bazzi C, Petrini C, Rizza V, et al. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int. Oct 2000;58(4):1732-41. [Medline].

  5. Dodge WF, Spargo BH, Travis LB, et al. Poststreptococcal glomerulonephritis. A prospective study in children. N Engl J Med. Feb 10 1972;286(6):273-8. [Medline].

  6. Neugarten J, Gallo GR, Baldwin DS. Glomerulonephritis in bacterial endocarditis. Am J Kidney Dis. Mar 1984;3(5):371-9. [Medline].

  7. Oda T, Yamakami K, Omasu F, et al. Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J Am Soc Nephrol. Jan 2005;16(1):247-54. [Medline].

  8. Rodriguez-Iturbe B. Nephritis-associated streptococcal antigens: where are we now?. J Am Soc Nephrol. Jul 2004;15(7):1961-2. [Medline].

  9. Rodríguez-Iturbe B. Epidemic poststreptococcal glomerulonephritis. Kidney Int. Jan 1984;25(1):129-36. [Medline].

  10. Ronco P, Verroust P, Morel-Maroger L. Viruses and Glomerulonephritis. Nephron. 1982;31(2):97-102. [Medline].

  11. Yoshizawa N, Yamakami K, Fujino M, et al. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol. Jul 2004;15(7):1785-93. [Medline].

Further Reading

Keywords

acute glomerulonephritis, acute nephritis, Bright disease, acute poststreptococcal glomerulonephritis, PSGN, acute postinfectious glomerulonephritis

Contributor Information and Disclosures

Author

Malvinder S Parmar, MB, MS, FRCP(C), FACP, Assistant Professor (VPT), Faculty of Medicine, University of Ottawa; Associate Professor, Department of Internal Medicine, Northern Ontario School of Medicine, Timmins and District Hospital, Canada
Malvinder S Parmar, MB, MS, FRCP(C), FACP is a member of the following medical societies: American College of Physicians, American Society of Nephrology, Canadian Medical Association, Ontario Medical Association, and Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.

Medical Editor

Chike Magnus Nzerue, MD, Associate Dean for Clinical Affairs, Meharry Medical College
Chike Magnus Nzerue, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Society of Nephrology, and National Kidney Foundation
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Ajay K Singh, MB, MRCP, MBA, Associate Professor of Medicine, Director of Dialysis, Department of Medicine, Harvard Medical School; Clinical Chief of Renal Division, Brigham and Women's Hospital
Disclosure: Nothing to disclose.

CME Editor

Rebecca J Schmidt, DO, FACP, FASN, Professor of Medicine, Section Chief, Department of Medicine, Section of Nephrology, West Virginia University School of Medicine
Rebecca J Schmidt, DO, FACP, FASN is a member of the following medical societies: American College of Osteopathic Internists, American College of Physicians, American Medical Association, American Society of Nephrology, International Society of Nephrology, National Kidney Foundation, Renal Physicians Association, and West Virginia State Medical Association
Disclosure: Abbott Grant/research funds Speaking and teaching; Genzyme Honoraria Consulting; Roche Honoraria Consulting

Chief Editor

Vecihi Batuman, MD, FACP, FASN, Professor of Medicine, Section of Nephrology-Hypertension, Tulane University School of Medicine; Chief, Medicine Service, Southeast Louisiana Veterans Health Care System
Vecihi Batuman, MD, FACP, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, and International Society of Nephrology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.